Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
27.02
-0.26 (-0.95%)
Nov 21, 2024, 1:19 PM EST - Market open
Q32 Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | -14.66 | -6.65 | 6.65 | - |
| Cost of Revenue | 45.94 | 31.73 | 35.81 | 29.93 |
| Gross Profit | -60.6 | -38.38 | -29.16 | -29.93 |
| Selling, General & Admin | 16.79 | 9.88 | 10.06 | 6.76 |
| Operating Expenses | 16.79 | 9.88 | 10.06 | 6.76 |
| Operating Income | -77.39 | -48.26 | -39.23 | -36.69 |
| Interest Expense | -1.3 | -0.5 | - | - |
| Interest & Investment Income | 4.2 | 1.2 | - | - |
| Other Non Operating Income (Expenses) | 16.45 | -5.87 | -3.52 | -0.32 |
| Pretax Income | -58.73 | -53.43 | -42.75 | -37.02 |
| Income Tax Expense | 1.88 | 0.32 | 0.06 | 0.55 |
| Net Income | -60.61 | -53.74 | -42.81 | -37.56 |
| Net Income to Common | -60.61 | -53.74 | -42.81 | -37.56 |
| Shares Outstanding (Basic) | 13 | 7 | 7 | 6 |
| Shares Outstanding (Diluted) | 13 | 7 | 7 | 6 |
| Shares Change (YoY) | 548.42% | 3.25% | 8.57% | - |
| EPS (Basic) | -4.57 | -7.41 | -6.09 | -5.81 |
| EPS (Diluted) | -5.76 | -7.41 | -6.09 | -5.81 |
| Free Cash Flow | -67.07 | -18.68 | -13.44 | -33.14 |
| Free Cash Flow Per Share | -5.06 | -2.58 | -1.91 | -5.12 |
| Operating Margin | - | - | -589.76% | - |
| Profit Margin | - | - | -643.65% | - |
| Free Cash Flow Margin | - | - | -202.10% | - |
| EBITDA | -76.89 | -47.76 | -38.86 | -36.65 |
| D&A For EBITDA | 0.49 | 0.5 | 0.37 | 0.05 |
| EBIT | -77.39 | -48.26 | -39.23 | -36.69 |
Source: S&P Capital IQ. Standard template.
Financial Sources.